1950. Prevention of Recurrent Clostridium difficile at Six Months Following Treatment With Microbiota-Based Therapy RBX2660: Durability Results From a Phase 2 Open-Label Study
diterbitkan dalam: Open Forum Infectious Diseases
tanggal publikasi: 2018-11
subyek utama: Clostridium difficile
Cites articles
There is nothing here
Artikel - wd:Q59334505